GaramszegiS, YenJY, HonkoAN, et al. (2014). Transcriptional correlates of disease outcome in anticoagulant-treated non-human primates infected with ebolavirus. PLoS Neglect Trop Dis, 8:e3061.
3.
GeisbertTW, HensleyLE, JahrlingPB, et al. (2003a) Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys. Lancet, 362:1953-1958.
4.
GeisbertTW, HensleyLE, LarsenT, et al. (2003b) Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection. Am J Pathol, 163:2347-2370.
McElroyAK, EricksonBR, FlietstraTD, et al. (2014) Ebola hemorrhagic fever: novel biomarker correlates of clinical outcome. J Infect Dis, 210:558-566.
8.
QiuX, WongG, AudetJ, et al. (2014) Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp. Nature, 514:47-53.
9.
ReedDS, HensleyLE, GeisbertJB, JahrlingPB, GeisbertTW (2004) Depletion of peripheral blood T lymphocytes and NK cells during the course of Ebola hemorrhagic fever in cynomolgus macaques. Viral Immunol, 17: 390-400.
10.
World Health Organization. Global alert and response: Ebola virus disease (EVD). Geneva, Switzerland: World Health Organization; 2014. Available at http://www.who.int/csr/don/archive/disease/ebola/en, accessed September25, 2014.